How Agencies Support Go-to-Market Planning for a Drug Launch
The roles agencies play in drug launch go-to-market planning: insights, positioning, creative, media, measurement setup, and timing.
The short answer
Agencies support drug launch go-to-market planning across several workstreams: market and customer insights, positioning and message development, creative and content, media planning and partner selection, data and measurement setup, and launch readiness. The brand team owns strategy and decisions; agencies bring specialist capacity and experience. Launches go best when agency roles are defined early, work is sequenced against label and approval timing, and measurement is ready on day one.
A drug launch involves more workstreams than most brand teams can staff alone. Agencies fill that gap. The value they add depends on how clearly roles and sequencing are set.
Workstreams and agency roles
| Workstream | Typical agency role | Brand team role |
|---|---|---|
| Insights | Research design and synthesis | Decide which questions matter |
| Positioning | Options and testing | Choose position |
| Messaging | Message house, testing | Approve with medical and regulatory |
| Creative | Concepts, campaigns, assets | Approve direction |
| Media | Plans, partners, buying | Set budget and priorities |
| Data and measurement | Setup and partner coordination | Own measurement framework |
| Launch readiness | Checklists and QA | Final readiness decisions |
Sequencing against approval
| Timing | Agency focus |
|---|---|
| 24 to 18 months before | Insights, disease education, segmentation |
| 18 to 12 months | Positioning, message testing, partner selection |
| 12 to 6 months | Creative by label scenario, media plans, measurement setup |
| 6 to 0 months | Production, review, media booking, QA |
| 0 to 6 months after | Launch execution, optimization, early reads |
See marketing a phase 3 drug and the drug launch media plan.
Planning for label scenarios
Agencies should prepare work for more than one label outcome. Ask for a plan showing what changes if the label is narrower or approval is delayed.
Organizing multiple agencies
- One shared launch plan and calendar.
- A clear lead for each workstream.
- Regular joint meetings.
- Shared target lists and measurement definitions.
See one agency or two for HCP and DTC.
Measurement on day one
Launch is when learning is most valuable. Make sure before approval:
- Measurement partners contracted.
- Control designs agreed.
- Baselines captured.
- Data flows tested.
Common mistakes
- Bringing media and measurement partners in late.
- One plan for one label scenario.
- Agencies working from different lists and definitions.
- No launch readiness review.
A launch readiness checklist for agencies
Use one checklist across all agencies, reviewed at 12, 6, and 1 month before expected approval.
| Area | Ready when |
|---|---|
| Target lists | Final HCP list and tiers shared with all partners; match rates known |
| Messages | Message house approved for each label scenario |
| Creative | Core assets in review; swap-ready versions for label scenarios |
| Media | Partners contracted; plans by scenario; insertion orders ready to activate |
| Field tools | Rep materials aligned with media messages |
| Patient support | Hub and savings programs live and linked from materials |
| Website | Brand sites built, reviewed, tracking approved by privacy |
| Measurement | Partners contracted; control design agreed; baseline captured |
| Safety | AE processes in place for social and digital |
| Governance | RACI, escalation path, and launch war-room schedule agreed |
The first 90 days
Agencies add most value after approval by moving fast on evidence:
- Week 1 to 2: confirm delivery, reach on target lists, and tag health.
- Week 3 to 6: early engagement and field feedback; adjust creative emphasis within approved materials.
- Week 6 to 12: first outcome reads where data allows; shift budget toward channels showing target reach and early outcome signals.
Agree in advance which data each agency will report and when, so the brand team sees one picture rather than several competing ones.
Practical takeaway
Twelve months before expected approval, run a readiness check with every agency against one shared checklist. Gaps found then can be fixed; gaps found the week of approval usually cannot.
Frequently asked questions
When should agencies be brought into launch planning?
Often 18 to 24 months before expected approval for major launches, with roles expanding as approval nears.
Which agencies are involved in a drug launch?
Commonly a strategic or creative agency for HCP, one for patients, a media agency, medical communications for scientific content (managed by medical), and specialist partners for data and measurement.
What is launch readiness?
A review that confirms materials, media, data, measurement, field tools, and support programs are ready for approval day.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.